Barbara A. Foster

28.0k total citations · 3 hit papers
138 papers, 9.0k citations indexed

About

Barbara A. Foster is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Barbara A. Foster has authored 138 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 51 papers in Pulmonary and Respiratory Medicine and 31 papers in Oncology. Recurrent topics in Barbara A. Foster's work include Prostate Cancer Treatment and Research (37 papers), Epigenetics and DNA Methylation (21 papers) and Immunotherapy and Immune Responses (12 papers). Barbara A. Foster is often cited by papers focused on Prostate Cancer Treatment and Research (37 papers), Epigenetics and DNA Methylation (21 papers) and Immunotherapy and Immune Responses (12 papers). Barbara A. Foster collaborates with scholars based in United States, Japan and Canada. Barbara A. Foster's co-authors include Norman M. Greenberg, Calman Prussin, Gerald R. Cunha, Michael J. Morin, Farzan Rastinejad, Dean D. Metcalfe, Eugene D. Kwon, Arthur A. Hurwitz, James P. Allison and Christopher Madias and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Barbara A. Foster

136 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological Rescue of Mutant p53 Conformation and Function

1999 647 citations Barbara A. Foster et al. profile →
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.

2000 355 citations Barbara A. Foster, Norman M. Greenberg et al. PubMed profile →
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1997 326 citations Barbara A. Foster, Norman M. Greenberg et al. profile →

Peers

Countries citing papers authored by Barbara A. Foster

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Foster more than expected).

Fields of papers citing papers by Barbara A. Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Foster. The network helps show where Barbara A. Foster may publish in the future.

Co-authorship network of co-authors of Barbara A. Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Foster. A scholar is included among the top collaborators of Barbara A. Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Foster. Barbara A. Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Comprehensive Review of Current Approaches in Bladder Cancer Treatment 2025 ·ACS Pharmacology & Translational Science ·(unknown), (unknown), Barbara A. Foster, Youngjae You	6
2	Comparison of red and green light for treating non‐muscle invasive bladder cancer in rats using singlet oxygen‐cleavable prodrugs with PPIX‐PDT 2024 ·Photochemistry and Photobiology ·(unknown), (unknown), Ganesh Bist, Sukyung Woo, Barbara A. Foster, Youngjae You	3
3	Enhancing PDT efficacy in NMIBC: Efflux inhibitor mediated improvement of PpIX levels and efficacy of the combination of PpIX‐PDT and SO‐cleavable prodrugs 2024 ·Photochemistry and Photobiology ·(unknown), (unknown), (unknown), Ganesh Bist, Barbara A. Foster, Sukyung Woo, Youngjae You	2
4	Mitochondrial targeting improves the selectivity of singlet‐oxygen cleavable prodrugs in NMIBC treatment 2024 ·Photochemistry and Photobiology ·(unknown), Ganesh Bist, (unknown), Barbara A. Foster, Sukyung Woo, Youngjae You	3
5	Preclinical evaluation of singlet oxygen‐cleavable prodrugs in combination with protoporphyrin IX‐photodynamic therapy in an orthotopic rat model of non‐muscle‐invasive bladder cancer 2023 ·Photochemistry and Photobiology ·(unknown), Barbara A. Foster, Youngjae You	2
6	Photodynamic Therapy for Bladder Cancers, A Focused Review^† 2022 ·Photochemistry and Photobiology ·(unknown), Prabhanjan Giram, Barbara A. Foster, Youngjae You	31
7	Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy 2020 ·Nature Communications ·Hayley C. Affronti, Aryn M. Rowsam, (unknown), Spencer R. Rosario, Mark D. Long, (unknown), Anna Bianchi, (unknown), Bryan M. Gillard, Ellen Karasik, Barbara A. Foster, Michael T. Moser, John H. Wilton, Kristopher Attwood, Mikhail A. Nikiforov, Gissou Azabdaftari, Роберто Пили, James G. Phillips, Robert A. Casero, Dominic J. Smiraglia	46
8	A simple quantitative PCR assay to determine TRAMP transgene zygosity 2020 ·Prostate Cancer and Prostatic Diseases ·Ruidong Chen, Xin Liang, (unknown), Ellen Karasik, Jenny Han, Ming Zhu, Barbara A. Foster, Daniel E. Frigo, Guocan Wang	1
9	Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation 2015 ·Stem Cells and Development ·(unknown), Courtney M. Jackson, (unknown), Anthony Jones, David W. Goodrich, Barbara A. Foster, Wendy J. Huss	9
10	In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer 2012 ·Molecular Cancer Therapeutics ·Chunqing Guo, Huanfa Yi, Xiaofei Yu, Daming Zuo, Jie Qian, Gary Yang, Barbara A. Foster, John R. Subjeck, Xiaolei Sun, Ross B. Mikkelsen, Paul B. Fisher, Xiang‐Yang Wang	28
11	Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation 2012 ·Cancer Research ·Steven R. Barthel, (unknown), (unknown), Matthew Opperman, Kempland C. Walley, Leonardo Nimrichter, Monica M. Burdick, Bryan M. Gillard, Michael T. Moser, Klaus Pantel, Barbara A. Foster, Kenneth J. Pienta, Charles J. Dimitroff	60
12	Dietary Folate Deficiency Blocks Prostate Cancer Progression in the TRAMP Model 2011 ·Cancer Prevention Research ·Gaia Bistulfi, Barbara A. Foster, Ellen Karasik, Bryan M. Gillard, (unknown), Vineet K. Dhiman, Dominic J. Smiraglia	35
13	Lack of Evidence for Green Tea Polyphenols as DNA Methylation Inhibitors in Murine Prostate 2009 ·Cancer Prevention Research ·Shannon R. Morey Kinney, Wa Zhang, Marién Pascual, John M. Greally, Bryan M. Gillard, Ellen Karasik, Barbara A. Foster, Adam R. Karpf	31
14	Phenotype-Specific CpG Island Methylation Events in a Murine Model of Prostate Cancer 2008 ·Cancer Research ·Marta Camoriano, Shannon R. Morey Kinney, Michael T. Moser, Barbara A. Foster, James L. Mohler, Donald L. Trump, Adam R. Karpf, Dominic J. Smiraglia	15
15	Loss of the ssecks/gravin/akap12 Gene Results in Prostatic Hyperplasia 2008 ·Cancer Research ·Shin Akakura, (unknown), Peter J. Nelson, Barbara A. Foster, Irwin H. Gelman	62
16	DNA Methylation Pathway Alterations in an Autochthonous Murine Model of Prostate Cancer 2006 ·Cancer Research ·(unknown), Dominic J. Smiraglia, Smitha R. James, Jihnhee Yu, Michael T. Moser, Barbara A. Foster, Adam R. Karpf	41
17	Inflammatory Responses to Pneumovirus Infection in IFN-αβR Gene-Deleted Mice 2005 ·The Journal of Immunology ·(unknown), Kimberly D. Dyer, John A. Ellis, Cynthia A. Bonville, Barbara A. Foster, Calman Prussin, Andrew J. Easton, Joseph B. Domachowske, Helene F. Rosenberg	50
18	Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. 2003 ·PubMed ·Kevin W. Freeman, Rama Gangula, Bryan E. Welm, Mustafa Özen, Barbara A. Foster, Jeffrey M. Rosen, Michael Ittmann, Norman M. Greenberg, David M. Spencer	68
19	IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis 2001 ·The Journal of Immunology ·Iain B. McInnes, Gabor G. Illei, Carol L. Danning, Cheryl Yarboro, (unknown), Takashi Kuroiwa, Ryan Schlimgen, Eric Lee, Barbara A. Foster, Donald J. Flemming, Calman Prussin, Thomas A. Fleisher, Dimitrios T. Boumpas	96
20	Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate 1996 ·The International Journal of Developmental Biology ·Yoshiki Sugimura, Barbara A. Foster, Yun K. Hom, Joshua H. Lipschutz, Jeffrey S. Rubin, Paul W. Finch, S A Aaronson, (unknown), Jun Kawamura, Gerald R. Cunha	141

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact